Compare CLF & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLF | PTCT |
|---|---|---|
| Founded | 1847 | 1998 |
| Country | United States | United States |
| Employees | 25000 | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.7B |
| IPO Year | 2006 | 2006 |
| Metric | CLF | PTCT |
|---|---|---|
| Price | $9.95 | $71.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $11.58 | ★ $80.65 |
| AVG Volume (30 Days) | ★ 13.8M | 732.2K |
| Earning Date | 04-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | N/A | ★ 7.78 |
| Revenue | ★ $18,610,000,000.00 | $264,734,000.00 |
| Revenue This Year | $8.76 | N/A |
| Revenue Next Year | $2.64 | $19.02 |
| P/E Ratio | ★ N/A | $9.24 |
| Revenue Growth | N/A | ★ 36.19 |
| 52 Week Low | $5.63 | $35.95 |
| 52 Week High | $16.70 | $87.50 |
| Indicator | CLF | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 57.86 |
| Support Level | $9.30 | $69.81 |
| Resistance Level | $9.91 | $79.59 |
| Average True Range (ATR) | 0.34 | 2.23 |
| MACD | 0.26 | 0.52 |
| Stochastic Oscillator | 94.75 | 80.47 |
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.